Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a hold rating to a buy rating in a research report report published on Thursday. Several other equities research analysts have also commented on the company. HC Wainwright upped their target price on Black Diamond Therapeutics from $11.00 to $12.00 and […]
Wall Street Zen upgraded shares of Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) from a hold rating to a buy rating in a research report report published on Thursday. Several other equities research analysts have also commented on the company. HC Wainwright upped their target price on Black Diamond Therapeutics from $11.00 to $12.00 and […]
